Clinical trials recruiting in San Sebastián, Spain
8
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 1Phase 3 4Phase 4 1Not applicable 2
Conditions recruiting in San Sebastián, Spain
Recruiting trials in San Sebastián, Spain
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)
- A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
- IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
- National GMA Post-market Clinical Follow-up Study (GRACE)
- Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
- Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Common questions
How many clinical trials are recruiting in San Sebastián, Spain?
8 recruiting trials have at least one study site in San Sebastián, Spain.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.